These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22515794)

  • 21. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and management of chemotherapy-induced nausea and vomiting.
    Moradian S; Howell D
    Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical management of chemotherapy-induced nausea and vomiting.
    Wiser W; Berger A
    Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
    Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Craver C; Gayle J; Balu S; Buchner D
    J Med Econ; 2011; 14(3):341-9. PubMed ID: 21542674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy.
    Moore S; Tumeh J; Wojtanowski S; Flowers C
    Value Health; 2007; 10(1):23-31. PubMed ID: 17261113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
    Bleicher J; Bhaskara A; Huyck T; Constantino S; Bardia A; Loprinzi CL; Silberstein PT
    J Support Oncol; 2008 Jan; 6(1):27-32. PubMed ID: 18257398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
    Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial.
    Dupuis LL; Kelly KM; Krischer JP; Langevin AM; Tamura RN; Xu P; Chen L; Kolb EA; Ullrich NJ; Sahler OJZ; Hendershot E; Stratton A; Sung L; McLean TW
    Cancer; 2018 Mar; 124(6):1188-1196. PubMed ID: 29266260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients.
    Dupuis LL; Robinson PD; Boodhan S; Holdsworth M; Portwine C; Gibson P; Phillips R; Maan C; Stefin N; Sung L;
    Pediatr Blood Cancer; 2014 Aug; 61(8):1506-12. PubMed ID: 24753095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Schwartzberg L; Morrow G; Balu S; Craver C; Gayle J; Cox D
    Curr Med Res Opin; 2011 Aug; 27(8):1613-22. PubMed ID: 21696263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Therapeutic Approaches for the Management and Control of Nausea in Children Undergoing Cancer Treatment: A Systematic Review of Literature.
    Momani TG; Berry DL
    J Pediatr Oncol Nurs; 2017; 34(3):173-184. PubMed ID: 28193133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of electroacupuncture with different acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial.
    Chen B; Hu SX; Liu BH; Zhao TY; Li B; Liu Y; Li MY; Pan XF; Guo YM; Chen ZL; Guo Y
    Trials; 2015 May; 16():212. PubMed ID: 25963295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acupressure for chemotherapy-associated nausea and vomiting in children.
    Jones E; Isom S; Kemper KJ; McLean TW
    J Soc Integr Oncol; 2008; 6(4):141-5. PubMed ID: 19134445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
    Reindl TK; Geilen W; Hartmann R; Wiebelitz KR; Kan G; Wilhelm I; Lugauer S; Behrens C; Weiberlenn T; Hasan C; Gottschling S; Wild-Bergner T; Henze G; Driever PH
    Support Care Cancer; 2006 Feb; 14(2):172-6. PubMed ID: 16021478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effectiveness of Hologram Bracelets in Reducing Chemotherapy-Induced Nausea and Vomiting Among Adult Patients With Cancer.
    Akhu-Zaheya LM; Khater WA; Lafi AY
    Cancer Nurs; 2017; 40(2):E17-E29. PubMed ID: 27088609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emetogenic potential of antineoplastic agents based on clinical trials in Japan].
    Watanabe T; Handa S; Kato Y
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):335-41. PubMed ID: 25812503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.